Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ESRRG |
| Upstream (Parents) |
|---|
| (<<) TFAP2B → ESRRG |
| (<<) SOX10 → ESRRG |
| (<<) FOXQ1 → ESRRG |
| (<<) FOXG1 → ESRRG |
| (<<) SPDEF → ESRRG |
| (<<) AR → ESRRG |
| (<<) NFIA → ESRRG |
| (<<) SLC26A3 → ESRRG |
| (<<) ARNTL2 → ESRRG |
| (<<) CREB3L4 → ESRRG |
| (<<) MSX2 → ESRRG |
| (<<) MECOM → ESRRG |
| (<<) TFAP2C → ESRRG |
| (<<) MYCL1 → ESRRG |
| (<<) TEAD4 → ESRRG |
| (<<) UHRF1 → ESRRG |
| (<<) CSDA → ESRRG |
| (<<) MEIS1 → ESRRG |
| (<<) HOXC13 → ESRRG |
| (<<) HMGB2 → ESRRG |
| (<<) ATF7 → ESRRG |
| (<<) PTTG1 → ESRRG |
| (<<) CEBPD → ESRRG |
| (<<) RELB → ESRRG |
| Downstream (Children) |
|---|
| ESRRG → ARNT2 (>>) |
| ESRRG → ETV7 (>>) |
| ESRRG → CUX2 (>>) |
| ESRRG → FBXW7 (>>) |
